APA

Sato A., Takano T., Hiramoto A., Naito T., Matsuda A., Fukushima M., Wataya Y. & Kim H. (20171204). Role of the uridine/cytidine kinase 2 mutation in cellular sensitiveness toward 3'-ethynylcytidine treatment of human cancer cells. : Anti-cancer drugs.

Chicago

Sato Akira, Takano Takeshi, Hiramoto Akiko, Naito Tomoharu, Matsuda Akira, Fukushima Masakazu, Wataya Yusuke and Kim Hye-Sook. 20171204. Role of the uridine/cytidine kinase 2 mutation in cellular sensitiveness toward 3'-ethynylcytidine treatment of human cancer cells. : Anti-cancer drugs.

Harvard

Sato A., Takano T., Hiramoto A., Naito T., Matsuda A., Fukushima M., Wataya Y. and Kim H. (20171204). Role of the uridine/cytidine kinase 2 mutation in cellular sensitiveness toward 3'-ethynylcytidine treatment of human cancer cells. : Anti-cancer drugs.

MLA

Sato Akira, Takano Takeshi, Hiramoto Akiko, Naito Tomoharu, Matsuda Akira, Fukushima Masakazu, Wataya Yusuke and Kim Hye-Sook. Role of the uridine/cytidine kinase 2 mutation in cellular sensitiveness toward 3'-ethynylcytidine treatment of human cancer cells. : Anti-cancer drugs. 20171204.